ERIS
NIFTY500
Eris Lifesciences Ltd.
Pharma · NSE
₹1,386.10
1Y-7.0%
52-week range
₹1,200 – ₹1,910
From 52w high
-27.4%
RSI (14)
54.5
vs SMA 50 / 200
↑ 50 · ↓ 200
PE
43.6
Forward PE
27.4
ROE
—
Profit margin
14.1%
D/E
68.19
Dividend yield
0.97%
Quality score
43/100
Revenue growth
10.9%
Earnings growth
19.1%
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.